| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.29B | -1.9% |
| Gross profit | ¥0.25B | — |
| Operating income | ¥0.06B | — |
| Net income | ¥0.05B | +60.9% |
| Gross margin | 19.6% | Net margin 3.7% |
| Revenue Q/Q | -28.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.04B | 80.4% |
| R&D | ¥0.05B | 4.1% |
| SG&A | ¥0.13B | 10.2% |
| Tax & other | ¥0.01B | 1.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
景嘉微 ・ 香农芯创 ・ ST合纵 ・ 杭州高新 ・ 神思电子 ・ 光力科技 ・ 濮阳惠成 ・ 万孚生物 ・ 首华燃气 ・ 蓝海华腾 ・ 赛升药业 ・ 东杰智能
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies